Compile Data Set for Download or QSAR
Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 9647
TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478066(US10889610, Example 13 | 5-Chloro-2-cyano-3-pyridy...)
Affinity DataKd:  11nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478065(US10889610, Example 12 | 5-Bromo-6-cyano-3-pyridyl...)
Affinity DataKd:  7.00E+3nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478059(US10889610, Example 7 | 4-Chloro-2-pyridyl 3-deoxy...)
Affinity DataKd:  6.90E+3nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478052(US10889610, Example 1 | 4-Bromo-5-cyano- 2-pyridyl...)
Affinity DataKd:  2.60E+3nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478075(US10889610, Example 22 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  694nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478074(US10889610, Example 21 | 5-Chloro-3-pyridyl 3-deox...)
Affinity DataKd:  31nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478073(US10889610, Example 20 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  750nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478072(US10889610, Example 19 | 5-Chloro-3-pyridyl 3-deox...)
Affinity DataKd:  34nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478071(US10889610, Example 18 | 5-Chloro-3-pyridyl 3-deox...)
Affinity DataKd:  27nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478070(US10889610, Example 17 | 5-Chloro-3-pyridyl 3-deox...)
Affinity DataKd:  28nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478069(US10889610, Example 16 | 5-Chloro-3-pyridyl 3-deox...)
Affinity DataKd:  18nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478068(US10889610, Example 15 | 5-Chloro-3-pyridyl 3-deox...)
Affinity DataKd:  97nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478067(US10889610, Example 14 | 5-Chloro-3-pyridyl 3-deox...)
Affinity DataKd:  180nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478052(US10889610, Example 1 | 4-Bromo-5-cyano- 2-pyridyl...)
Affinity DataKd:  27nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478065(US10889610, Example 12 | 5-Bromo-6-cyano-3-pyridyl...)
Affinity DataKd:  16nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478064(US10889610, Example 11 | 5-Bromo-2-cyano-3-pyridyl...)
Affinity DataKd:  11nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478063(US10889610, Example 10 | 5-Chloro-6-cyano-3-pyridy...)
Affinity DataKd:  18nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478062(US10889610, Example 9 | 5-Chloro-3-pyridyl 3-deoxy...)
Affinity DataKd:  22nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478061(US10889610, Example 8 | 5-Bromo-3-pyridyl 3-deoxy-...)
Affinity DataKd:  15nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478059(US10889610, Example 7 | 4-Chloro-2-pyridyl 3-deoxy...)
Affinity DataKd:  120nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478058(US10889610, Example 6 | 5-Bromo-2-cyano-3-pyridyl ...)
Affinity DataKd:  22nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478057(US10889610, Example 5 | 5-Bromo-6-cyano-3-pyridyl ...)
Affinity DataKd:  22nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478056(US10889610, Example 4 | 5-Chloro-2-cyano-3-pyridyl...)
Affinity DataKd:  29nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478055(US10889610, Example 3 | 2-Chloro-4-pyridyl 3-deoxy...)
Affinity DataKd:  86nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM478053(US10889610, Example 2 | 4-Chloro-5-cyano-2-pyridyl...)
Affinity DataKd:  57nMAssay Description:The affinity of Example 1-22 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent